INDUCED COVID-19 ENDOTHELIUM DYSFUNCTION AND POSSIBLE WAYS OF PHARMACOLOGICAL CORRECTION
The COVID-19 pandemic has been going on for two years. Clinical experience has shown that with COVID-19, endothelial dysfunction develops and, as a result, the synthesis of nitric oxide decreases. The stages of the formation of endothelial dysfunction in COVID-19, as well as the ways of its pharmacological correction that exist today are considered. The prospects for the use of dihydroquercetin and L-arginine at the stage of convalescence after suffering COVID-19 are being evaluated.